Long-Acting Injectables Stratµm

Discover how Adare Pharma Solutions is revolutionizing injectable solutions with their Stratµm Technology Platform. Adare Pharma Solutions is a leading provider of solutions for complex oral dosage form challenges, offering expertise in product development and GMP commercial manufacturing. With over 40 commercial products globally and partnerships with over 100 pharmaceutical companies, they are a trusted name in the industry.

In a significant development, Adare Pharma Solutions has acquired Orbis Biosciences, expanding their capabilities in taste masking and controlled release solutions for pharmaceutical products. These solutions offer uniformity, dose flexibility, taste masking, and variable release kinetics in a microcapsule or microparticle format.

Adare Pharma Solutions has developed technologies that enable the production of controlled release powders, ensuring uniformity in particle size and precise control of release kinetics. This addresses limitations in current microsphere manufacturing methods, such as dose dumping and unpredictable drug release. The limitations of certain medications can negatively impact patients' quality of life, leading to larger injection volumes, more frequent administrations, and discomfort. Adare Pharma Solutions' Stratµm technology offers targeted fixes for these limitations, including narrowing particle size distribution, improving encapsulation, and implementing a single-step coating process.

Long-acting injectables have clinical value, and Adare Pharma Solutions' Stratµm technology offers tangible value for certain applications. Patients can now experience improved outcomes and comfort with injectables.